US Stock MarketDetailed Quotes

INmune Bio (INMB)

Watchlist
  • 1.695
  • +0.235+16.10%
Trading May 14 13:42 ET
45.06MMarket Cap-1.04P/E (TTM)

INmune Bio (INMB) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
50.13%-3.4M
32.31%-22.58M
73.27%-2.94M
22.14%-5.44M
6.48%-7.38M
8.72%-6.82M
-178.47%-33.36M
-223.82%-11.01M
-63.84%-6.99M
-148.46%-7.89M
Net income from continuing operations
44.48%-5.41M
-9.15%-45.93M
42.89%-5.26M
46.48%-6.47M
-150.95%-24.46M
11.66%-9.74M
-40.24%-42.08M
-9.63%-9.22M
-41.22%-12.09M
-49.92%-9.75M
Depreciation and amortization
--52K
--84K
--56K
----
----
--0
--0
--0
----
----
Other non cash items
---91K
-892.41%-626K
--0
----
----
----
-64.73%79K
-86.67%6K
-72.22%15K
-58.62%24K
Change In working capital
-34.92%546K
-344.07%-2.53M
70.43%-1.05M
-140.11%-1.35M
-87.74%-965K
-51.67%839K
-90.06%1.04M
-215.41%-3.56M
43.17%3.37M
-136.56%-514K
-Change in receivables
53,971.43%3.77M
-403.19%-3.13M
-18,981.82%-2.08M
-115.50%-309K
-2.21%-739K
97.18%-7K
-82.84%1.03M
106.15%11K
1,018.43%1.99M
-540.85%-723K
-Change in prepaid assets
-179.84%-99K
-119.98%-264K
-122.45%-123K
-75.37%33K
-350.42%-298K
-76.15%124K
-45.16%1.32M
568.38%548K
-88.85%134K
-87.22%119K
-Change in payables and accrued expense
-509.50%-3.02M
235.20%1.86M
121.88%893K
-126.88%-329K
680.28%554K
-47.88%737K
-163.20%-1.37M
-220.81%-4.08M
-14.88%1.22M
-82.07%71K
-Change in other current assets
-393.33%-88K
-1,092.31%-516K
4,933.33%151K
-17,500.00%-176K
-2,184.00%-521K
20.00%30K
262.50%52K
250.00%3K
-200.00%-1K
180.65%25K
-Change in other current liabilities
-150.00%-20K
272.00%43K
1,585.71%104K
-1,120.00%-61K
214.29%8K
-33.33%-8K
-525.00%-25K
-170.00%-7K
-25.00%-5K
69.57%-7K
-Change in other working capital
----
-1,946.43%-517K
--0
-1,925.00%-511K
3,000.00%31K
-219.35%-37K
122.05%28K
-357.14%-32K
143.75%28K
103.23%1K
Cash from discontinued investing activities
Operating cash flow
50.13%-3.4M
32.31%-22.58M
73.27%-2.94M
22.14%-5.44M
6.48%-7.38M
8.72%-6.82M
-178.47%-33.36M
-223.82%-11.01M
-63.84%-6.99M
-148.46%-7.89M
Investing cash flow
Cash flow from continuing investing activities
-1.04M
-143K
-193K
0
0
0
Net PPE purchase and sale
----
---1.04M
---143K
---193K
----
----
--0
--0
--0
----
Cash from discontinued investing activities
Investing cash flow
----
---1.04M
---143K
---193K
----
----
--0
--0
--0
----
Financing cash flow
Cash flow from continuing financing activities
0
51.62%27.61M
103.22%67K
0
71.35%22.27M
310.96%5.27M
531.03%18.21M
16.88%-2.08M
667.65%9.79M
13M
Net issuance payments of debt
----
--0
--0
--0
--0
--0
-100.00%-10M
0.00%-2.5M
0.00%-2.5M
---2.5M
Net common stock issuance
--0
-0.88%27.54M
--0
--0
43.71%22.27M
--5.27M
3,485.68%27.79M
--0
1,486.06%12.29M
--15.5M
Proceeds from stock option exercised by employees
--0
-83.89%68K
-84.12%67K
--0
--0
--1K
--422K
--422K
--0
--0
Cash from discontinued financing activities
Financing cash flow
--0
51.62%27.61M
103.22%67K
--0
71.35%22.27M
310.96%5.27M
531.03%18.21M
16.88%-2.08M
667.65%9.79M
--13M
Net cash flow
Beginning cash position
18.30%24.75M
-41.64%20.92M
-17.34%27.73M
7.42%33.37M
-25.63%19.34M
-41.64%20.92M
-31.26%35.85M
-19.76%33.55M
-35.04%31.07M
-49.02%26M
Current changes in cash
-119.55%-3.4M
126.32%3.99M
76.93%-3.02M
-300.71%-5.63M
177.64%14.19M
84.46%-1.55M
6.51%-15.15M
-121.84%-13.09M
146.85%2.81M
261.03%5.11M
Effect of exchange rate changes
128.57%10K
-170.98%-159K
-91.97%37K
97.52%-8K
-247.73%-153K
-126.92%-35K
324.00%224K
820.31%461K
-1,304.35%-323K
-1,000.00%-44K
End cash Position
10.45%21.36M
18.30%24.75M
18.30%24.75M
-17.34%27.73M
7.42%33.37M
-25.63%19.34M
-41.64%20.92M
-41.64%20.92M
-19.76%33.55M
-35.04%31.07M
Free cash flow
50.13%-3.4M
29.19%-23.62M
71.97%-3.09M
19.38%-5.63M
-2.47%-8.08M
8.72%-6.82M
-178.47%-33.36M
-223.82%-11.01M
-63.84%-6.99M
-148.46%-7.89M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 50.13%-3.4M32.31%-22.58M73.27%-2.94M22.14%-5.44M6.48%-7.38M8.72%-6.82M-178.47%-33.36M-223.82%-11.01M-63.84%-6.99M-148.46%-7.89M
Net income from continuing operations 44.48%-5.41M-9.15%-45.93M42.89%-5.26M46.48%-6.47M-150.95%-24.46M11.66%-9.74M-40.24%-42.08M-9.63%-9.22M-41.22%-12.09M-49.92%-9.75M
Depreciation and amortization --52K--84K--56K----------0--0--0--------
Other non cash items ---91K-892.41%-626K--0-------------64.73%79K-86.67%6K-72.22%15K-58.62%24K
Change In working capital -34.92%546K-344.07%-2.53M70.43%-1.05M-140.11%-1.35M-87.74%-965K-51.67%839K-90.06%1.04M-215.41%-3.56M43.17%3.37M-136.56%-514K
-Change in receivables 53,971.43%3.77M-403.19%-3.13M-18,981.82%-2.08M-115.50%-309K-2.21%-739K97.18%-7K-82.84%1.03M106.15%11K1,018.43%1.99M-540.85%-723K
-Change in prepaid assets -179.84%-99K-119.98%-264K-122.45%-123K-75.37%33K-350.42%-298K-76.15%124K-45.16%1.32M568.38%548K-88.85%134K-87.22%119K
-Change in payables and accrued expense -509.50%-3.02M235.20%1.86M121.88%893K-126.88%-329K680.28%554K-47.88%737K-163.20%-1.37M-220.81%-4.08M-14.88%1.22M-82.07%71K
-Change in other current assets -393.33%-88K-1,092.31%-516K4,933.33%151K-17,500.00%-176K-2,184.00%-521K20.00%30K262.50%52K250.00%3K-200.00%-1K180.65%25K
-Change in other current liabilities -150.00%-20K272.00%43K1,585.71%104K-1,120.00%-61K214.29%8K-33.33%-8K-525.00%-25K-170.00%-7K-25.00%-5K69.57%-7K
-Change in other working capital -----1,946.43%-517K--0-1,925.00%-511K3,000.00%31K-219.35%-37K122.05%28K-357.14%-32K143.75%28K103.23%1K
Cash from discontinued investing activities
Operating cash flow 50.13%-3.4M32.31%-22.58M73.27%-2.94M22.14%-5.44M6.48%-7.38M8.72%-6.82M-178.47%-33.36M-223.82%-11.01M-63.84%-6.99M-148.46%-7.89M
Investing cash flow
Cash flow from continuing investing activities -1.04M-143K-193K000
Net PPE purchase and sale -------1.04M---143K---193K----------0--0--0----
Cash from discontinued investing activities
Investing cash flow -------1.04M---143K---193K----------0--0--0----
Financing cash flow
Cash flow from continuing financing activities 051.62%27.61M103.22%67K071.35%22.27M310.96%5.27M531.03%18.21M16.88%-2.08M667.65%9.79M13M
Net issuance payments of debt ------0--0--0--0--0-100.00%-10M0.00%-2.5M0.00%-2.5M---2.5M
Net common stock issuance --0-0.88%27.54M--0--043.71%22.27M--5.27M3,485.68%27.79M--01,486.06%12.29M--15.5M
Proceeds from stock option exercised by employees --0-83.89%68K-84.12%67K--0--0--1K--422K--422K--0--0
Cash from discontinued financing activities
Financing cash flow --051.62%27.61M103.22%67K--071.35%22.27M310.96%5.27M531.03%18.21M16.88%-2.08M667.65%9.79M--13M
Net cash flow
Beginning cash position 18.30%24.75M-41.64%20.92M-17.34%27.73M7.42%33.37M-25.63%19.34M-41.64%20.92M-31.26%35.85M-19.76%33.55M-35.04%31.07M-49.02%26M
Current changes in cash -119.55%-3.4M126.32%3.99M76.93%-3.02M-300.71%-5.63M177.64%14.19M84.46%-1.55M6.51%-15.15M-121.84%-13.09M146.85%2.81M261.03%5.11M
Effect of exchange rate changes 128.57%10K-170.98%-159K-91.97%37K97.52%-8K-247.73%-153K-126.92%-35K324.00%224K820.31%461K-1,304.35%-323K-1,000.00%-44K
End cash Position 10.45%21.36M18.30%24.75M18.30%24.75M-17.34%27.73M7.42%33.37M-25.63%19.34M-41.64%20.92M-41.64%20.92M-19.76%33.55M-35.04%31.07M
Free cash flow 50.13%-3.4M29.19%-23.62M71.97%-3.09M19.38%-5.63M-2.47%-8.08M8.72%-6.82M-178.47%-33.36M-223.82%-11.01M-63.84%-6.99M-148.46%-7.89M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More